SEARCH

SEARCH BY CITATION

References

  • Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR & Tufik S (2010) Angiotensin-converting enzyme polymorphism and erectile dysfunction complaints in the Brazilian population. J Sex Med 7, 27912797.
  • Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U et al. (2001a) Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 58, 805810.
  • Becker AJ, Uckert S, Stief CG, Truss MC, Machtens S, Scheller F et al. (2001b) Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 57, 193198.
  • Begg CB & Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 10881101.
  • Burnett AL (2006) Erectile dysfunction. J Urol 175, S25S31.
  • Çam FS, Gümüş BH, Var A & Berdeli A (2011) Association of angiotensin- converting enzyme I/D and eNOS G894T gene polymorphisms with erectile dysfunction. Turkiye Klinikleri J Med Med Sci 31, 432437. Turkey.
  • DerSimonian R & Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177188.
  • Egger MJ & Smith GD (1998) Bias in location and selection of studies. BMJ 316, 6167.
  • Eisenhardt A & Siffert W (2003) Genetic risk factors for erectile dysfunction and genetic determinants of drug response-on the way to improve drug safety? Herz 28, 304313.
  • Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rubben H et al. (2003) ACE gene ID and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 62, 152157.
  • Eisenhardt A, Stief C, Porst H, Wetterauer U, Weidner W, Rubben H et al. (2010) Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population. Andrologia 42, 218224.
  • Erdos EG & Skidgel RA (1987) The angiotensin I-converting enzyme. Lab Invest 56, 345348.
  • Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ & McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the massachusetts male aging study. J Urol 151, 5461.
  • Gamidov SI, Iremashvili VV & Nosikov VV (2011) The role of angiotensin- converting enzyme gene polymorphism in development of erectile dysfunction in patients with metabolic syndrome. Urologiia 1, 3437. Russian.
  • Haiman CA, Henderson SO, Bretsky P, Kolonel LN & Henderson BE (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 63, 69846987.
  • Higgins JP & Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 15391558.
  • Jackson G (2009) Sexual response in cardiovascular disease. J Sex Res 46, 233236.
  • Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P & Dluhy RG (1997) Tissue angiotensin II as a modulator of erectile function. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 157, 19201925.
  • Kim DS, Choi SI, Lee HS, Park JK & Yi HK (2001) Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction: frequency differences of ACE gene polymorphisms according to the method of analysis. Clin Chem Lab Med 39, 1114.
  • Kitsios G & Zintzaras E (2009) ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet 4, 1050.
  • Kloner RA (2008) Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res 20, 460465.
  • Llisterri JL, Lozano VJ, Aznar VJ, Argaya RM, Pol BC, Sanchez ZM et al. (2001) Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 321, 336341.
  • Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S et al. (2004) Summary of the recommendations on sexual dysfunctions in men. J Sex Med 1, 623.
  • Mazo EB, Gamidov SI, Mamedov MN & Iremashvili VV (2008) Association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and erectile dysfunction in patients with metabolic syndrome. Int J Impot Res 20, 6872.
  • Melman A & Gingell JC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161, 511.
  • Mollsten A, Stegmayr B & Wiklund PG (2008) Genetic polymorphisms in the renin- angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study. J Hypertens 26, 13671372.
  • Park JK, Kim SZ, Kim SH, Park YK & Cho KW (1997) Renin angiotensin system in rabbit corpus cavernosum: functional characterization of angiotensin II receptors. J Urol 158, 653658.
  • Park JK, Kim W, Kim SW, Koh GY & Park SK (1999) Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with erectile dysfunction. Int J Impot Res 11, 273276.
  • Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, Oliveira PS et al. (2007) Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens 25, 17631774.
  • Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P & Soubrier F (1990) An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 13431346.
  • Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B et al. (2005) The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11, 25262530.
  • Rosas-Vargas H, Coral-Vazquez RM, Tapia R, Borja JL, Salas RA & Salamanca F (2004) Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J Androl 25, 728732.
  • Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V et al. (2009) Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 6, 34253432.
  • Sayed-Tabatabaei FA, Oostra BA, Isaacs A, Van Duijn CM & Witteman JC (2006) ACE polymorphisms. Circ Res 98, 11231133.
  • Selvin E, Burnett AL & Platz EA (2007) Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120, 151157.
  • Smith JF, Caan BJ, Sternfeld B, Haque R, Quesenberry CP Jr, Quinn VP et al. (2009) Racial disparities in erectile dysfunction among participants in the California men's health study. J Sex Med 6, 34333439.
  • Sullivan ME, Keoghane SR & Miller MAW (2001) Vascular risk factors and erectile dysfunction. BJU Int 87, 838845.
  • Teles AG, Carreira M, Alarcao V, Sociol D, Aragues JM, Lopes L et al. (2008) Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med 5, 13171324.
  • Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8, 1517.
  • Tsai CT, Hwang JJ, Ritchie MD, Moore JH, Chiang FT, Lai LP et al. (2007) Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 195, 172180.
  • Wang J-L, Wang H-G, Gao H-Q, Zhai G-X, Chang P & Chen Y-G (2010) Endothelial nitric oxide synthase polymorphisms and erectile dysfunction: a meta-analysis. J Sex Med 7, 38893898.
  • Wiwanitkit V (2005) Correlation between angiotensin converting enzyme I/D polym- orphism and erectile dysfunction: an appraisal. Sex Disabil 23, 109113.
  • Zintzaras E & Ioannidis JP (2005) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28, 123137.
  • Zintzaras E & Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61, 634645.